Detailed information for compound 185411

Basic information

Technical information
  • TDR Targets ID: 185411
  • Name: tert-butyl N-[(1R,2S)-1-[(4R,7S)-5,8-dioxo-7- propan-2-yl-12,15,18-trioxa-3,6,9-triazabicyc lo[17.3.1]tricosa-1(23),19,21-trien-4-yl]-1-h ydroxy-3-phenylpropan-2-yl]carbamate
  • MW: 642.783 | Formula: C34H50N4O8
  • H donors: 5 H acceptors: 4 LogP: 3.49 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 2
  • SMILES: O=C(OC(C)(C)C)N[C@H]([C@H]([C@H]1NCc2cccc(c2)OCCOCCOCCNC(=O)[C@@H](NC1=O)C(C)C)O)Cc1ccccc1
  • InChi: 1S/C34H50N4O8/c1-23(2)28-31(40)35-14-15-43-16-17-44-18-19-45-26-13-9-12-25(20-26)22-36-29(32(41)38-28)30(39)27(21-24-10-7-6-8-11-24)37-33(42)46-34(3,4)5/h6-13,20,23,27-30,36,39H,14-19,21-22H2,1-5H3,(H,35,40)(H,37,42)(H,38,41)/t27-,28-,29+,30+/m0/s1
  • InChiKey: DQRZWWANHBNSDX-VZNYXHRGSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • tert-butyl N-[(1S,2R)-1-benzyl-2-hydroxy-2-[(4R,7S)-7-isopropyl-5,8-dioxo-12,15,18-trioxa-3,6,9-triazabicyclo[17.3.1]tricosa-1(23),19,21-trien-4-yl]ethyl]carbamate
  • N-[(1S,2R)-1-benzyl-2-hydroxy-2-[(4R,7S)-7-isopropyl-5,8-dioxo-12,15,18-trioxa-3,6,9-triazabicyclo[17.3.1]tricosa-1(23),19,21-trien-4-yl]ethyl]carbamic acid tert-butyl ester
  • tert-butyl N-[(1R,2S)-1-[(4R,7S)-5,8-dioxo-7-propan-2-yl-12,15,18-trioxa-3,6,9-triazabicyclo[17.3.1]tricosa-1(23),19,21-trien-4-yl]-1-hydroxy-3-phenyl-propan-2-yl]carbamate
  • N-[(1S,2R)-1-benzyl-2-hydroxy-2-[(4R,7S)-7-isopropyl-5,8-diketo-12,15,18-trioxa-3,6,9-triazabicyclo[17.3.1]tricosa-1(23),19,21-trien-4-yl]ethyl]carbamic acid tert-butyl ester
  • tert-butyl N-[(1S,2R)-2-hydroxy-2-[(4R,7S)-7-isopropyl-5,8-dioxo-12,15,18-trioxa-3,6,9-triazabicyclo[17.3.1]tricosa-1(23),19,21-trien-4-yl]-1-(phenylmethyl)ethyl]carbamate
  • N-[(1S,2R)-2-hydroxy-2-[(4R,7S)-7-isopropyl-5,8-dioxo-12,15,18-trioxa-3,6,9-triazabicyclo[17.3.1]tricosa-1(23),19,21-trien-4-yl]-1-(phenylmethyl)ethyl]carbamic acid tert-butyl ester
  • N-[(1S,2R)-1-(benzyl)-2-hydroxy-2-[(4R,7S)-7-isopropyl-5,8-diketo-12,15,18-trioxa-3,6,9-triazabicyclo[17.3.1]tricosa-1(23),19,21-trien-4-yl]ethyl]carbamic acid tert-butyl ester
  • 180968-41-6
  • AIDS-028578
  • AIDS028578
  • (1'S,2'S,9S,15R)-15-(2'-(((1,1-Dimethylethoxy)carbonyl)amino)-1'-hydroxy-3'-phenylprop-1'-yl)-12-(1-methylethyl)-10,13,16-triaza-1,4,7-trioxa-11,14-dioxo(17)metacyclophane
  • (1'S,2'S,9S,15R)-15-[2'-[[(1,1-Dimethylethoxy)carbonyl]amino]-1'-hydroxy-3'-phenylprop-1'-yl]-12-(1-methylethyl)-10,13,16-triaza-1,4,7-trioxa-11,14-dioxo[17]metacyclophane
  • 1OH-2BocNH-3PhPr [17]Metacyclophane deriv.

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Human immunodeficiency virus 1 Human immunodeficiency virus type 1 protease Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Schistosoma mansoni intracisternal A-particle retropepsin (A02 family) Get druggable targets OG5_131408 All targets in OG5_131408

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Candida albicans dethiobiotin synthetase Human immunodeficiency virus type 1 protease   99 aa 90 aa 22.2 %
Entamoeba histolytica retroviral aspartyl protease domain-containing protein Human immunodeficiency virus type 1 protease   99 aa 103 aa 31.1 %
Trypanosoma brucei variant surface glycoprotein (VSG), putative Human immunodeficiency virus type 1 protease   99 aa 80 aa 27.5 %
Giardia lamblia DNA-directed RNA polymerase subunit D Human immunodeficiency virus type 1 protease   99 aa 90 aa 27.8 %
Candida albicans dethiobiotin synthetase Human immunodeficiency virus type 1 protease   99 aa 90 aa 22.2 %
Echinococcus multilocularis Chromobox protein 3 Human immunodeficiency virus type 1 protease   99 aa 95 aa 28.4 %
Entamoeba histolytica retroviral aspartyl protease domain-containing protein Human immunodeficiency virus type 1 protease   99 aa 103 aa 31.1 %
Mycobacterium leprae Hypothetical protein Human immunodeficiency virus type 1 protease   99 aa 86 aa 27.9 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Brugia malayi Trypsin-like protease protein 5 0.055 0.2916 1
Onchocerca volvulus 0.055 0.2916 1
Onchocerca volvulus 0.055 0.2916 1
Loa Loa (eye worm) hypothetical protein 0.055 0.2916 1
Echinococcus granulosus subfamily S1A unassigned peptidase S01 family 0.055 0.2916 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.055 0.2916 0.2179
Echinococcus granulosus glycoprotein Antigen 5 0.055 0.2916 1
Echinococcus multilocularis Peptidase S1 S6, chymotrypsin Hap 0.055 0.2916 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.055 0.2916 0.2179
Onchocerca volvulus 0.055 0.2916 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.055 0.2916 0.2179
Mycobacterium tuberculosis Carboxylesterase LipT 0.0148 0 0.5
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Echinococcus granulosus fatty acid amide hydrolase 1 0.0502 0.2567 0.6197
Loa Loa (eye worm) hypothetical protein 0.055 0.2916 1
Loa Loa (eye worm) hypothetical protein 0.055 0.2916 1
Echinococcus granulosus Peptidase S1 S6 chymotrypsin Hap 0.055 0.2916 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.055 0.2916 0.2179
Loa Loa (eye worm) trypsin family protein 0.055 0.2916 1
Loa Loa (eye worm) hypothetical protein 0.055 0.2916 1
Loa Loa (eye worm) hypothetical protein 0.055 0.2916 1
Echinococcus granulosus Mastin 0.055 0.2916 1
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Echinococcus granulosus fatty acid amide hydrolase 1 0.0502 0.2567 0.6197
Schistosoma mansoni hypothetical protein 0.055 0.2916 0.2179
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Brugia malayi Trypsin family protein 0.055 0.2916 1
Loa Loa (eye worm) hypothetical protein 0.055 0.2916 1
Brugia malayi Trypsin family protein 0.055 0.2916 1
Brugia malayi Trypsin family protein 0.055 0.2916 1
Echinococcus multilocularis Mastin 0.055 0.2916 1
Loa Loa (eye worm) hypothetical protein 0.055 0.2916 1
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Trypanosoma brucei lipase domain protein, putative 0.0424 0.1998 0.5
Loa Loa (eye worm) hypothetical protein 0.0502 0.2567 0.6197
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.055 0.2916 0.2179
Schistosoma mansoni fatty-acid amide hydrolase 0.0502 0.2567 0.1794
Brugia malayi Chymotrypsin-like protease CTRL-1 precursor 0.055 0.2916 1
Echinococcus multilocularis transmembrane protease serine 3 0.055 0.2916 1
Schistosoma mansoni hypothetical protein 0.055 0.2916 0.2179
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Trichomonas vaginalis lipase containing protein, putative 0.0424 0.1998 0.5
Schistosoma mansoni amidase 0.0502 0.2567 0.1794
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Schistosoma mansoni aminopeptidase PILS (M01 family) 0.055 0.2916 0.2179
Echinococcus granulosus enteropeptidase 0.055 0.2916 1
Brugia malayi Trypsin family protein 0.055 0.2916 1
Brugia malayi amidase 0.0502 0.2567 0.6197
Echinococcus multilocularis fatty acid amide hydrolase 1 0.0502 0.2567 0.6197
Leishmania major hypothetical protein, conserved 0.0424 0.1998 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0424 0.1998 0.5
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Onchocerca volvulus 0.055 0.2916 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.055 0.2916 0.2179
Echinococcus granulosus transmembrane protease serine 3 0.055 0.2916 1
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Trypanosoma brucei lipase domain protein, putative 0.0424 0.1998 0.5
Echinococcus multilocularis enteropeptidase 0.055 0.2916 1
Trypanosoma cruzi hypothetical protein, conserved 0.0424 0.1998 0.5
Onchocerca volvulus 0.055 0.2916 1
Echinococcus multilocularis glycoprotein Antigen 5 0.055 0.2916 1
Echinococcus multilocularis subfamily S1A unassigned peptidase (S01 family) 0.055 0.2916 1
Mycobacterium ulcerans hypothetical protein 0.055 0.2916 1
Schistosoma mansoni subfamily S1A unassigned peptidase (S01 family) 0.055 0.2916 0.2179
Trichomonas vaginalis lipase containing protein, putative 0.0424 0.1998 0.5
Brugia malayi hypothetical protein 0.055 0.2916 1
Onchocerca volvulus 0.055 0.2916 1
Schistosoma mansoni cercarial elastase (S01 family) 0.055 0.2916 0.2179
Echinococcus multilocularis fatty acid amide hydrolase 1 0.0502 0.2567 0.6197

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 3000 nM Antiviral activity against HIV-1 IIIB induced cytopathic effect in de novo infected MT-4 cells ChEMBL. 8765512
Ki (binding) = 207.7 nM Inhibition of HIV-1 proteinase was assayed in infected MT-4 cells ChEMBL. 8765512
Ki (binding) = 207.7 nM Inhibition of HIV-1 proteinase was assayed in infected MT-4 cells ChEMBL. 8765512
Solubility = 607 mM Aqueous solubility of the compound was determined in phosphate buffer of pH 7.4 ChEMBL. 8765512

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.